Detection of Unsaturated Disaccharides, Pyridinoline, and Hydroxyproline in Urine of Patients with Kashin-Beck Disease: Comparison with Controls in an Endemic Area

REFERENCES

1. 1.↵
   1. Wang Z

   . A historical overview on research and control of Kashin-Beck disease in China. In: Proceedings of the International Academic Seminar on Kaschin-Beck Disease and Correlated Diseases, January 22, 1999, Beijing. Chin J Endemic 1999;18:161–3.

   OpenUrl
2. 2.↵
   1. Ministry of Public Health, Development and Reformation Committee, Ministry of Finance

   . China national intensive endemic prevention and control project. Beijing, China; September 2004.
3. 3.↵
   1. Yang J

   . The discussion on the medication for adult Kaschin-Beck disease. Chin J Endemic 2005;24:87–90.

   OpenUrl
4. 4.↵
   1. Bayliss MT,
   2. Osborne D,
   3. Woodhouse S,
   4. Davidson C

   . Sulfate of chondroitin sulfate in human articular cartilage. J Biol Chem 1999;274:15892–900.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Freeman MA

   1. Maroudas A

   . Physico-chemical properties of articular cartilage. In: Freeman MA, editor. Adult articular cartilage. 2nd ed. Tunbridge Wells: Pitman Medical; 1979:145–214.
6. 6.↵
   1. Poole AR,
   2. Kobayashi M,
   3. Yasuda T,
   4. et al

   . Type II collagen degradation and its regulation in articular cartilage in osteoarthritis. Ann Rheum Dis 2002;61:ii78–81.

   OpenUrlFREE Full Text
7. 7.↵
   1. Delmas PD,
   2. Eastell R,
   3. Garnero P,
   4. Seibel MJ,
   5. Stepan J

   . The use of biochemical markers of bone turnover in osteoporosis. Osteoporos Int 2000;11 Suppl 6:S2–17.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Stanbury JB,
   2. Wyngaarden JB,
   3. Fredrickson DS

   1. Scriver CR,
   2. Efron ML

   . Disorders of proline and hydroxyproline metabolism. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, editors. The metabolic basis of inherited disease. 3rd ed. New York: McGraw-Hill; 1972:351–8.
9. 9.↵
   1. Ministry of Public Health

   . Diagnostic criteria of Kaschin Beck disease. Beijing, China; December 1995.
10. 10.↵
    1. Sakai S,
    2. Onose J-I,
    3. Nakamura H,
    4. et al

    . Pretreatment procedure for the microdetermination of chondroitin sulfate in plasma and urine. Anal Biochem 2002;302:169–74.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Sharif M,
    2. Osborne J,
    3. Meadows K,
    4. et al

    . The relevance of chondroitin and keratan sulphate markers in normal and arthritic synovial fluid. Br J Rheumatol 1996;35:951–7.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Gunja-Smith Z,
    2. Boucek RJ

    . Collagen cross-linking compounds in human urine. Biochem J 1981;197:759–62.

    OpenUrlAbstract/FREE Full Text
13. 13.↵
    1. McLaren AM,
    2. Horden LD,
    3. Bird HA,
    4. Robins SP

    . Urinary excretion of pyridinium crosslinks of collagen in patients with osteoporosis and the effects of bone fracture. Ann Rheum Dis 1992;51:648–51.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Robins SP,
    2. Black D,
    3. Paterson CR,
    4. Reid DM,
    5. Duncan A,
    6. Siebel MJ

    . Evaluation of hydroxypyridinium crosslinks as resorption markers in metabolic bone disease. Eur J Clin Invest 1991;21:310–5.

    OpenUrlPubMed
15. 15.↵
    1. Astbury C,
    2. Bird HA,
    3. McLaren AM,
    4. Robins SP

    . Urinary excretion of pyridinium crosslinks of collagen correlated with joint damage in arthritis. Br J Rheumatol 1994;33:11–5.

    OpenUrlAbstract/FREE Full Text
16. 16.↵
    1. Siebel MJ,
    2. Duncan A,
    3. Robins SP

    . Urinary hydroxyl-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic disease. J Rheumatol 1989;16:964–70.

    OpenUrlPubMed
17. 17.↵
    1. Robins SP

    . An enzyme-linked immunoassay for the collagen cross-link pyridinoline. Biochem J 1982;207:617–20.

    OpenUrlAbstract/FREE Full Text
18. 18.↵
    1. Fujimoto D,
    2. Suzuki M,
    3. Uchiyama A,
    4. Miyamoto S,
    5. Inoue T

    . Analysis of pyridinoline, a cross-linking compound of collagen fibers, in human urine. Biochem 1983;94:1133–6.

    OpenUrl
19. 19.↵
    1. Christenson RH

    . Biochemical markers of bone metabolism [overview]. Clin Biochem 1997;30:573–93.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Clemens JD,
    2. Herrick MV,
    3. Singer FR,
    4. Eyre DR

    . Evidence that serum NTx (collagen-type telopeptides) can act as an immunochemical marker of bone resorption. Clin Chem 1997;43:2058–63.

    OpenUrlAbstract/FREE Full Text
21. 21.↵
    1. Prockop DJ,
    2. Kivirikko KI,
    3. Tuderman L,
    4. Guzman NA

    . The biosynthesis of collagen and its disorders (first of 2 parts). N Engl J Med 1979;301:13–23.

    OpenUrlCrossRefPubMed
22. 22.↵
    1. Frame B,
    2. Potts JT, Jr

    1. Kivirikko KI

    . Excretion of urinary hydroxyproline peptide in the assessment of bone collagen deposition and resorption. In: Frame B, Potts JT, Jr, editors. Clinical disorders of bone and mineral metabolism. Amsterdam: Excerpta Medica; 1983:105–7.
23. 23.↵
    1. Kanis JA,
    2. McCloskey EV

    . Bone turnover and biochemical markers in malignancy. Cancer 1997;80:1538–45.

    OpenUrlCrossRefPubMed
24. 24.↵
    1. Delmas PD

    . What do we know about biochemical bone markers? Baillieres Clin Obstet Gynaecol 1991;5:817–30.

    OpenUrlCrossRefPubMed
25. 25.↵
    1. Delmas PD

    . Biochemical markers of bone turnover. J Bone Miner Res 1993;8 Suppl 2:S549–55.

    OpenUrlCrossRefPubMed
26. 26.↵
    1. Deftos LJ

    . Bone protein and peptide assays in the diagnosis and management of skeletal disease. Clin Chem 1991;37:1143–8.

    OpenUrlAbstract/FREE Full Text
27. 27.↵
    1. Watts NB

    . Clinical utility of biochemical markers of bone remodeling. Clin Chem 1999;45:1359–68.

    OpenUrlAbstract/FREE Full Text
28. 28.↵
    1. Demers LM,
    2. Costa L,
    3. Lipton A

    . Biochemical markers and skeletal metastases. Cancer 2000;88:2919–26.

    OpenUrlCrossRefPubMed
29. 29.↵
    1. Kleerekoper M,
    2. Edelson GW

    . Biochemical studies in the evaluation and management of osteoporosis: current status and future prospects. Endocrin Pract 1996;2:13–9.

    OpenUrl